Group Leader

Research Group Home Page: 

Work address: 
Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE
Publications: 

Development of a ‘mouse and human cross-reactive’ affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy.

E-pub date: 01 Jun 2014


Increased ERK signalling promotes inflammatory signalling in primary airway epithelial cells expressing Z α1-antitrypsin.

E-pub date: 15 Feb 2014


Tissue inhibitor of metalloproteinases-3 peptides inhibit angiogenesis and choroidal neovascularization in mice.

E-pub date: 31 Aug 2013


Anti-tumour effects of a specific anti-ADAM17 antibody in an ovarian cancer model in vivo.

E-pub date: 31 Aug 2012


A heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesis.

E-pub date: 31 Aug 2012


Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1.

E-pub date: 31 Jul 2012


LPS activates ADAM9 dependent shedding of ACE from endothelial cells.

E-pub date: 27 Apr 2012


Lactoferricin mediates anabolic and anti-catabolic effects in the intervertebral disc.

E-pub date: 01 Apr 2012


Pentosan polysulfate increases affinity between ADAMTS-5 and TIMP-3 through formation of an electrostatically driven trimolecular complex.

E-pub date: 01 Apr 2012


Membrane type 1 matrix metalloproteinase (MT1-MMP) ubiquitination at Lys581 increases cellular invasion through type I collagen.

E-pub date: 30 Mar 2012


Inhibition of MT1-MMP activity using functional antibody fragments selected against its hemopexin domain.

E-pub date: 01 Feb 2012


Tissue inhibitors of metalloproteinases.

E-pub date: 11 Nov 2011


Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness.

E-pub date: 01 Nov 2011


Modulation of integrin α4β1 by ADAM28 promotes lymphocyte adhesion and transendothelial migration.

E-pub date: 31 Oct 2011


Mechanism of heparin acceleration of tissue inhibitor of metalloproteases-1 (TIMP-1) degradation by the human neutrophil elastase.

E-pub date: 31 Aug 2011


Biochemistry meets biology: key findings for bone calcification and a lifetime philosophy of collaboration.

E-pub date: 31 Aug 2011


Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes.

E-pub date: 11 Aug 2011


Two novel determinants of etoposide resistance in small cell lung cancer.

E-pub date: 15 Jul 2011


Cross-domain inhibition of TACE ectodomain.

E-pub date: 05 Apr 2011


Localizing matrix metalloproteinase activities in the pericellular environment.

E-pub date: 31 Jan 2011


MT1-MMP regulates VEGF-A expression through a complex with VEGFR-2 and Src.

E-pub date: 01 Dec 2010


Bcl-2 and β1-integrin predict survival in a tissue microarray of small cell lung cancer.

E-pub date: 23 Nov 2010


Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.

E-pub date: 31 Aug 2010


Golgi reassembly stacking protein 55 interacts with membrane-type (MT) 1-matrix metalloprotease (MMP) and furin and plays a role in the activation of the MT1-MMP zymogen.

E-pub date: 31 Aug 2010


Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).

E-pub date: 15 Aug 2010


Tissue banking of diagnostic lung cancer biopsies for extraction of high quality RNA.

E-pub date: 31 Jul 2010


The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function.

E-pub date: 27 Jul 2010


Thiol isomerases negatively regulate the cellular shedding activity of ADAM17.

E-pub date: 27 May 2010


Role of the netrin-like domain of procollagen C-proteinase enhancer-1 in the control of metalloproteinase activity.

E-pub date: 21 May 2010


The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environment.

E-pub date: 01 Apr 2010


Regulation of the proteolytic disintegrin metalloproteinases, the ‘Sheddases’.

E-pub date: 01 Apr 2009


Cutting edge: the metalloproteinase ADAM17/TNF-alpha-converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein.

E-pub date: 31 Dec 2008


The ADAMs: signalling scissors in the tumour microenvironment.

E-pub date: 31 Dec 2008


Progress in matrix metalloproteinase research.

E-pub date: 31 Oct 2008


MT1-MMP regulates urothelial cell invasion via transcriptional regulation of Dickkopf-3.

E-pub date: 19 Aug 2008


The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: implications for airway remodeling in asthma.

E-pub date: 01 Jun 2008


The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.

E-pub date: 15 Apr 2008


Engineering adeno-associated virus 2 vectors for targeted gene delivery to atherosclerotic lesions.

E-pub date: 31 Mar 2008


Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?

E-pub date: 31 Mar 2008


Granulocyte-macrophage colony stimulating factor induces endothelial capillary formation through induction of membrane-type 1 matrix metalloproteinase expression in vitro.

E-pub date: 15 Mar 2008


Clipping, shedding and RIPping keep immunity on cue.

E-pub date: 01 Feb 2008


Membrane-type 1-matrix metalloproteinase regulates intracellular adhesion molecule-1 (ICAM-1)-mediated monocyte transmigration.

E-pub date: 24 Aug 2007


TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4.

E-pub date: 20 Jul 2007


Membrane-type 1 matrix metalloproteinase stimulates cell migration through epidermal growth factor receptor transactivation.

E-pub date: 01 Jun 2007


Src-dependent phosphorylation of membrane type I matrix metalloproteinase on cytoplasmic tyrosine 573: role in endothelial and tumor cell migration.

E-pub date: 25 May 2007


Identification of the extracellular matrix (ECM) binding motifs of tissue inhibitor of metalloproteinases (TIMP)-3 and effective transfer to TIMP-1.

E-pub date: 02 Mar 2007


Increased matrix metalloproteinase-13 production with aging by human articular chondrocytes in response to catabolic stimuli.

E-pub date: 01 Sep 2005


The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5′ bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.

E-pub date: 01 Mar 2004


Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail.

E-pub date: 01 Aug 2003


Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13.

E-pub date: 30 Nov 2002


Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

E-pub date: 30 Sep 2002


The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs.

E-pub date: 30 Jun 2002


The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3.

E-pub date: 30 Apr 2000


Localisation of matrix metalloproteinases and TIMP-2 in resorbing mouse bone.

E-pub date: 01 Mar 2000


Inhibition of the metalloproteinase domain of mouse TACE.

E-pub date: 31 May 1999


Evaluation of some newer matrix metalloproteinases.

E-pub date: 31 May 1999


Mechanisms for pro matrix metalloproteinase activation.

E-pub date: 01 Jan 1999


TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.

E-pub date: 31 Aug 1998


Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3.

E-pub date: 31 Mar 1998


The TIMP2 membrane type 1 metalloproteinase “receptor” regulates the concentration and efficient activation of progelatinase A. A kinetic study.

E-pub date: 31 Dec 1997


MT1-MMP on the cell surface causes focal degradation of gelatin films.

E-pub date: 31 Dec 1997


Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases.

E-pub date: 30 Nov 1997


Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13).

E-pub date: 31 Aug 1997


Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens.

E-pub date: 31 Mar 1997


Relating matrix metalloproteinase structure to function: why the “hemopexin” domain?

E-pub date: 01 Mar 1997


Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro.

E-pub date: 28 Feb 1997


The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction.

E-pub date: 28 Feb 1997


Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases.

E-pub date: 28 Feb 1997


Analysis of the contribution of the hinge region of human neutrophil collagenase (HNC, MMP-8) to stability and collagenolytic activity by alanine scanning mutagenesis.

E-pub date: 28 Feb 1997


Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution.

E-pub date: 31 Jan 1997


Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: characterization of their infection into rabbit smooth muscle cells and human MCF-7 adenocarcinoma cells.

E-pub date: 01 Dec 1996


The recognition sites of the integrins alpha1beta1 and alpha2beta1 within collagen IV are protected against gelatinase A attack in the native protein.

E-pub date: 31 Oct 1996


Chemically and conformationally authentic active domain of human tissue inhibitor of metalloproteinases-2 refolded from bacterial inclusion bodies.

E-pub date: 30 Sep 1996


Different susceptibilities of fibulin-1 and fibulin-2 to cleavage by matrix metalloproteinases and other tissue proteases.

E-pub date: 31 Aug 1996


The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.

E-pub date: 30 Jun 1996


Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.

E-pub date: 30 Jun 1996


Metalloproteinase-mediated regulation of L-selectin levels on leucocytes.

E-pub date: 30 Apr 1996


Degradation of cartilage aggrecan by collagenase-3 (MMP-13).

E-pub date: 31 Jan 1996


Biochemical characterization of human collagenase-3.

E-pub date: 31 Dec 1995


The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP2): structural implications for its function.

E-pub date: 31 Dec 1995


Activation of human neutrophil procollagenase by stromelysin 2.

E-pub date: 31 Dec 1995


Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes.

E-pub date: 30 Nov 1995


Gelatinase A possesses a beta-secretase-like activity in cleaving the amyloid protein precursor of Alzheimer’s disease.

E-pub date: 30 Nov 1995


Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities.

E-pub date: 31 Aug 1995


Evidence for the importance of weakly bound water for matrix metalloproteinase activity.

E-pub date: 31 Aug 1995


Gelatinases A and B.

E-pub date: 01 Aug 1995


Tissue inhibitors of matrix metalloendopeptidases.

E-pub date: 01 Aug 1995


Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes.

E-pub date: 01 Jul 1995


Binding of gelatinases A and B to type-I collagen and other matrix components.

E-pub date: 30 Jun 1995


The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family.

E-pub date: 31 May 1995


Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases.

E-pub date: 31 Mar 1995


The second zinc atom in the matrix metalloproteinase catalytic domain is absent in the full-length enzymes: a possible role for the C-terminal domain.

E-pub date: 31 Dec 1994


Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan.

E-pub date: 30 Nov 1994


Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts.

E-pub date: 31 Oct 1994


Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family.

E-pub date: 30 Sep 1994


Regulation of matrix metalloproteinase activity.

E-pub date: 31 Aug 1994


The binding of gelatinases A and B to type I collagen yields both high and low affinity sites.

E-pub date: 31 Aug 1994


Neutrophil procollagenase can be activated by stromelysin-2.

E-pub date: 31 Aug 1994


Folding and stability of the active N-terminal domain of tissue inhibitor of metalloproteinases-1 and -2.

E-pub date: 31 Aug 1994


Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1.

E-pub date: 30 Apr 1994


Proteolysis of human native and oxidised alpha 1-proteinase inhibitor by matrilysin and stromelysin.

E-pub date: 28 Feb 1994


Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.

E-pub date: 28 Feb 1994


Metalloproteinase domain structure, cellular invasion and metastasis.

E-pub date: 01 Feb 1994


Sites of nidogen cleavage by proteases involved in tissue homeostasis and remodelling.

E-pub date: 31 Oct 1993


Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain.

E-pub date: 30 Sep 1993


Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein.

E-pub date: 30 Sep 1993


Structural analysis of tissue inhibitor of metalloproteinases-1 (TIMP-1) by tryptic peptide mapping.

E-pub date: 31 May 1993


The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A.

E-pub date: 31 Mar 1993


Cell-mediated degradation of type IV collagen and gelatin films is dependent on the activation of matrix metalloproteinases.

E-pub date: 30 Nov 1992


The role of plasminogen activators in the regulation of connective tissue metalloproteinases.

E-pub date: 30 Nov 1992


Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13.

E-pub date: 30 Sep 1992


Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinases.

E-pub date: 31 Aug 1992


The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases.

E-pub date: 01 Jun 1992


The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases.

E-pub date: 30 Apr 1992


A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.

E-pub date: 31 Dec 1991


Metalloproteinase digestion of cartilage proteoglycan. Pattern of cleavage by stromelysin and susceptibility to collagenase.

E-pub date: 31 Oct 1991


Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization.

E-pub date: 31 Aug 1991


The origin of matrix metalloproteinases and their familial relationships.

E-pub date: 31 Aug 1991


The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.

E-pub date: 31 Jul 1991


The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity.

E-pub date: 31 Jul 1991


Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes.

E-pub date: 31 Jul 1991


Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).

E-pub date: 30 Jun 1991


Isolation and characterisation of a chicken gelatinase (type IV collagenase).

E-pub date: 30 Jun 1991


Purification of recombinant human prostromelysin. Studies on heat activation to give high-Mr and low-Mr active forms, and a comparison of recombinant with natural stromelysin activities.

E-pub date: 30 Apr 1991


Purification and characterization of human 72-kDa gelatinase (type IV collagenase). Use of immunolocalisation to demonstrate the non-coordinate regulation of the 72-kDa and 95-kDa gelatinases by human fibroblasts.

E-pub date: 01 Apr 1991


Proteolytic inactivation of human alpha 1 antitrypsin by human stromelysin.

E-pub date: 31 Jan 1991


Role and regulation of metalloproteinases in connective tissue turnover.

E-pub date: 01 Oct 1990


Immunoassays for the detection of human collagenase, stromelysin, tissue inhibitor of metalloproteinases (TIMP) and enzyme-inhibitor complexes.

E-pub date: 01 Oct 1990


Metalloproteinases and cartilage proteoglycan depletion in chronic arthritis. Comparison of antigen-induced and polycation-induced arthritis.

E-pub date: 01 Feb 1990


Metalloproteinases and cancer invasion and metastasis.

E-pub date: 30 Sep 1989


Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor.

E-pub date: 31 Jul 1989


Collagenase is expressed by rabbit VX2 tumour cells in syngeneic and xenogeneic hosts.

E-pub date: 01 Jun 1989


Human and rat malignant-tumor-associated mRNAs encode stromelysin-like metalloproteinases.

E-pub date: 31 May 1989


Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members.

E-pub date: 31 May 1989


Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin 1: evidence that breakdown is mediated by metalloproteinases.

E-pub date: 01 May 1989


The role of plasminogen in cell-mediated collagen degradation.

E-pub date: 01 Apr 1989


Degradation of proteoglycan aggregate by a cartilage metalloproteinase. Evidence for the involvement of stromelysin in the generation of link protein heterogeneity in situ.

E-pub date: 31 Mar 1989


Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase.

E-pub date: 28 Feb 1989


Degradation of glomerular basement membrane by purified mammalian metalloproteinases.

E-pub date: 31 Aug 1988


Relationship of procollagenase activator, stromelysin and matrix metalloproteinase 3.

E-pub date: 01 Jul 1988


Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes.

E-pub date: 31 Oct 1987


Comparison of human stromelysin and collagenase by cloning and sequence analysis.

E-pub date: 30 Nov 1986


Characterization of a specific antiserum to rabbit stromelysin and demonstration of the synthesis of collagenase and stromelysin by stimulated rabbit articular chondrocytes.

E-pub date: 01 Oct 1986


Rapid purification of tissue inhibitor of metalloproteinases from human plasma and identification as a gamma-serum protein.

E-pub date: 31 Aug 1986


Inhibition of type I collagen film degradation by tumour cells using a specific antibody to collagenase and the specific tissue inhibitor of metalloproteinases (TIMP).

E-pub date: 01 Dec 1985


Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity.

E-pub date: 31 Oct 1985


Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen.

E-pub date: 31 Aug 1985


Tissue inhibitor of metalloproteinases. Identification of precursor forms synthesized by human fibroblasts in culture.

E-pub date: 31 Mar 1985


Metalloproteinase inhibitors from bovine cartilage and body fluids.

E-pub date: 31 Jan 1984


Effects of retinol and dexamethasone on cytokine-mediated control of metalloproteinases and their inhibitors by human articular chondrocytes and synovial cells in culture.

E-pub date: 31 Aug 1983


The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor.

E-pub date: 30 Apr 1983


Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components.

E-pub date: 28 Feb 1983


Messenger function of prostaglandins in cell to cell interactions and control of proteinase activity in the rheumatoid joint.

E-pub date: 01 Aug 1982


Effects of products from macrophages, blood mononuclear cells and or retinol on collagenase secretion and collagen synthesis in chondrocyte culture.

E-pub date: 30 Jun 1982


Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens.

E-pub date: 31 Mar 1982


Characterization of collagenase, other metallo-proteinases and an inhibitor (TIMP) produced by human synovium and cartilage in culture.

E-pub date: 01 Dec 1981


Production of collagenase and inhibitor (TIMP) by normal, rheumatoid and osteoarthritic synovium in vitro: effects of hydrocortisone and indomethacin.

E-pub date: 01 Dec 1981


Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin.

E-pub date: 30 Nov 1981


Mammalian collagenases.

E-pub date: 01 Aug 1981


The production in culture of metalloproteinases and an inhibitor by joint tissues from normal rabbits, and from rabbits with a model arthritis. II. Articular cartilage.

E-pub date: 01 Aug 1981


The production in culture of metalloproteinases and an inhibitor by joint tissues from normal rabbits, and from rabbits with a model arthritis. I. Synovium.

E-pub date: 01 Aug 1981


Collagenolytic enzymes and their naturally occurring inhibitors.

E-pub date: 01 Aug 1981


An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases.

E-pub date: 31 Mar 1981


Purification of rabbit bone inhibitor of collagenase.

E-pub date: 31 Mar 1981


The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes.

E-pub date: 31 Oct 1980


Rabbit bone collagenase inhibitor blocks the activity of other neutral metalloproteinases.

E-pub date: 28 Feb 1979


Proteinase inhibitors of bovine nasal cartilage.

E-pub date: 28 Feb 1978


An inhibitor of mammalian collagenase from foetal rabbit bone in culture.

E-pub date: 01 Aug 1977


Collagenase activity from cultured non-gravid rabbit uterus.

E-pub date: 01 Aug 1977


A new factor that may control collagen resorption.

E-pub date: 31 Jul 1977


The detection and characterisation of collagenase inhibitors from rabbit tissues in culture.

E-pub date: 31 Jul 1977


Evidence that latent collagenases are enzyme-inhibitor complexes.

E-pub date: 30 Apr 1977


Collagenase is a component of the specific granules of human neutrophil leucocytes.

E-pub date: 31 Dec 1976


Show all